Zdrowie i gospodarka · 10/06/2021
FDA Releases Draft Guidance for Industry on Core Patient-Reported Outcomes in Cancer Clinical Trials
The FDA has announced the availability of a draft guidance for industry on collecting core patient-reported clinical outcomes in cancer clinical trials, aiming to generate high-quality data on patient-reported symptom and functional impacts.